Format

Send to

Choose Destination
Support Care Cancer. 2016 Feb;24(2):933-941. doi: 10.1007/s00520-015-2864-9. Epub 2015 Aug 13.

Elemental diet plus glutamine for the prevention of mucositis in esophageal cancer patients receiving chemotherapy: a feasibility study.

Author information

1
Department of Surgical Oncology, Gifu Graduate School of Medicine, 1-1 Yanagido, Gifu City, Gifu, 501-1194, Japan. yoshihirotana11@hotmail.com.
2
Department of Surgical Oncology, Gifu Graduate School of Medicine, 1-1 Yanagido, Gifu City, Gifu, 501-1194, Japan.
3
Graduate School of Medicine and Engineering, University of Yamanashi, 4-4-37 Takeda, Kofu City, 400-8510, Japan.

Abstract

PURPOSE:

We investigated the effect of glutamine (Gln) and an elemental diet (ED) on chemotherapy-induced oral mucositis in esophageal cancer patients.

METHODS:

Thirty patients were randomized to the control group (no treatment: n = 10), Gln group (oral intake of 8910 mg Gln/day: n = 10), or Gln plus ED group (total oral intake of 8862 mg Gln/day, including the Gln in ED: n = 10). Oral administration of Gln and ED began 1 week before chemotherapy and continued during treatment. Oral mucositis was evaluated during 2 cycles of chemotherapy using Common Terminology Criteria for Adverse Events v3.0.

RESULTS:

The incidence of grade ≥2 oral mucositis was 60 % in the control group, 70 % in the Gln group, and 10 % in the Gln plus ED group. Gln plus ED showed a significant preventive effect on the development and severity of oral mucositis. By multivariate analysis, Gln plus ED and cancer stage were independent factors affecting chemotherapy-induced oral mucositis. The percentage of change in body weight and diamine oxidase activity from before chemotherapy was higher in the Gln plus ED group than in the control group.

CONCLUSIONS:

Oral administration of Gln plus ED may prevent chemotherapy-induced oral mucositis in esophageal cancer patients.

KEYWORDS:

Chemotherapy; Elemental diet; Esophageal cancer; Glutamine; Mucositis

PMID:
26266659
PMCID:
PMC4689762
DOI:
10.1007/s00520-015-2864-9
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center